Table 1.
Baseline characteristics of the participants
| Characteristic | Control (n = 597) | Case | Pvs.controls | ||
|---|---|---|---|---|---|
|
|
|
||||
| CAD (n = 584) | IS (n = 555) | CAD | IS | ||
| Male/female | 434/163 | 428/156 | 405/150 | 0.861 | 0.991 |
| Age, years | 61.32±9.76 | 62.23±10.63 | 62.86±12.11 | 0.121 | 0.051 |
| Body mass index, kg/m2 | 22.41±2.86 | 23.84±3.38 | 24.71±22.04 | 0.000 | 0.015 |
| Systolic blood pressure, mmHg | 130.60±20.01 | 133.03±23.33 | 147.72±22.15 | 0.059 | 0.000 |
| Diastolic blood pressure, mmHg | 82.94±13.37 | 79.18±14.21 | 83.78±12.97 | 0.000 | 0.284 |
| Pulse pressure, mmHg | 49.81±14.70 | 53.49±18.08 | 64.02±17.92 | 0.000 | 0.000 |
| Cigarette smoking, n (%) | 236 (39.5) | 250(42.8) | 233(42.0) | 0.253 | 0.398 |
| Alcohol consumption, n (%) | 235 (39.4) | 131(22.4) | 157(28.3) | 0.000 | 0.000 |
| Total cholesterol, mmol/L | 4.93±1.11 | 4.53±1.19 | 4.52±1.15 | 0.000 | 0.010 |
| Triglyceride, mmol/L | 1.42±1.87 | 1.66±1.11 | 1.67±1.36 | 0.007 | 0.000 |
| HDL-C, mmol/L | 1.90±0.50 | 1.14±0.34 | 1.23±0.40 | 0.000 | 0.000 |
| LDL-C, mmol/L | 2.74±0.80 | 2.71±1.00 | 2.68±0.90 | 0.550 | 0.245 |
| Apolipoprotein (Apo) A1, g/L | 1.41±0.28 | 1.04±0.52 | 1.02±0.22 | 0.000 | 0.000 |
| ApoB, g/L | 0.91±0.22 | 0.91±0.27 | 0.89±0.25 | 0.995 | 0.320 |
| ApoA1/ApoB | 1.63±0.49 | 1.36±2.45 | 1.26±0.60 | 0.013 | 0.000 |
CAD, coronary artery disease; IS, ischemic stroke; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.